In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products

被引:114
作者
Foster, BC [1 ]
Vandenhoek, S
Hana, J
Krantis, A
Akhtar, MH
Bryan, M
Budzinski, JW
Ramputh, A
Arnason, JT
机构
[1] Hlth Canada, Therapeut Prod Directorate, Off Sci, Ottawa, ON K1A 1B6, Canada
[2] Univ Ottawa, Ctr Res Biopharmaceut, Ottawa, ON, Canada
[3] Agr & Agri Food Canada, Guelph, ON, Canada
[4] Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada
关键词
cytochrome P450; inhibition; herbal teas; drug interactions; nutraceuticals; spices; soybean;
D O I
10.1078/094471103322004839
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Spices, herbal and black teas, and soybean products were analyzed for their capacity to inhibit in vitro metabolism of drug marker substrates by human cytochrome P-450 (CYP) isoforms. Inhibition of drug metabolism was determined using aliquots or infusions from these products in a fluorescence-detection assay. Aliquots and infusions of all natural product categories inhibited 3A4 metabolism to some extent. Of the 26 aliquots from teas and spices further tested with 2C9, 2C19 and 2D6, many demonstrated significant inhibitory activity on the metabolism mediated by these isoforms. Black teas and herbal tea mixtures were generally more inhibitory than single-entity herbal teas. Spices and single-entity herbal teas showed species-specific isoform inhibition with sage, thyme, cloves, St John's Wort and goldenseal having the highest activity against several isoforms. Seven soybean varieties tested, as well as daidzein and genistein isolated from soybean, were found to inhibit 3A4-mediated metabolism. Genistein was found to inhibit 3A7- but not 3A5-mediated metabolism of the marker substrate. Assessment of the in vitro CYP inhibition potential for these natural products has important implications for predicting the likelihood of natural product-drug interactions if these products are taken concomitantly.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 37 条
[1]   Drug interactions with grapefruit juice [J].
Ameer, B ;
Weintraub, RA .
CLINICAL PHARMACOKINETICS, 1997, 33 (02) :103-121
[2]   PARTHENOLIDE CONTENT OF FEVERFEW (TANACETUM-PARTHENIUM)ASSESSED BY HPLC AND H-1-NMR SPECTROSCOPY [J].
AWANG, DVC ;
DAWSON, BA ;
KINDACK, DG ;
CROMPTON, CW ;
HEPTINSTALL, S .
JOURNAL OF NATURAL PRODUCTS, 1991, 54 (06) :1516-1521
[3]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[4]   Fiddleheads and the international normalized ratio [J].
Bartle, WR ;
Ferland, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1550-1550
[5]   Consumer use of St. John's wort: A survey on effectiveness, safety, and tolerability [J].
Beckman, SE ;
Sommi, RW ;
Switzer, J .
PHARMACOTHERAPY, 2000, 20 (05) :568-574
[6]   An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures [J].
Budzinski, JW ;
Foster, BC ;
Vandenhoek, S ;
Arnason, JT .
PHYTOMEDICINE, 2000, 7 (04) :273-282
[7]   Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450 [J].
Crespi, CL ;
Miller, VP ;
Penman, BW .
ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :188-190
[8]  
Eagling VA, 1999, BRIT J CLIN PHARMACO, V48, P543, DOI 10.1046/j.1365-2125.1999.00052.x
[9]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[10]   Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. [J].
Erdelmeier, CAJ .
PHARMACOPSYCHIATRY, 1998, 31 :2-6